DGAP-News: Analogic Corporation /
Analogic Announces Agreement to Distribute Prostate Guidance Solution
09.04.2014 / 23:00
---------------------------------------------------------------------
Analogic to Offer D&K's BioJet Fusion System With Flex Focus Ultrasound for
Precise, Targeted Prostate Biopsies
PEABODY, Mass., 2014-04-09 23:00 CEST (GLOBE NEWSWIRE) --
Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and
aviation security technology, announced today that it has entered into a
distribution agreement with D&K Technologies, developer of the BioJet(tm)
Solution, a revolutionary 3D MRI transrectal ultrasound (TRUS) fusion
technology. Analogic will distribute the BioJet system for use with its BK Flex
Focus(tm) ultrasound systems, for assistance during precise, targeted prostate
biopsies, in Austria, Belgium, Denmark, Germany, Great Britain, Luxemburg,
North America, Sweden Switzerland, and The Netherlands.
The BioJet Fusion system overlays real-time ultrasound images from the BK Flex
Focus ultrasound system with MRI identified lesions to provide real-time
guidance during prostate biopsies. Analogic's European launch of this advanced
technology for MRI/ultrasound fusion guided biopsies will take place at the
29th Annual European Association of Urology (EAU) Congress in Stockholm,
Sweden, April 11-15.
'We are very excited to distribute the BioJet System by D&K Technologies, a
complementary combination of MRI for lesion visualization and real-time
ultrasound for enhanced biopsy guidance,' said Farley Peechatka, senior vice
president and general manager of the Ultrasound Business at Analogic. 'In
particular, the targeted biopsies will help to guide physicians to potential
regions of interest in the prostate that previously may have been missed.
Precise, targeted biopsies will potentially reduce the incidence of under- and
over-treatment of lesions.'
The combination of the Flex Focus and BioJet offers a complete system that will
support both transperineal and transrectal biopsy methods. The BK endocavity
biplane transducer (8848) is ideal for transperineal fusion biopsies. In
addition, there are two options for transrectal fusion biopsies -- the BK
triplane (8818) and BK biplane transducer (8808e). Data is easily imported and
exported allowing for a more convenient working process between urologists and
radiologists. Comprehensive biopsy reports contain fused MRI and ultrasound
images, and biopsy cores. The complete system is simple to use with an
intuitive user interface that includes easy contouring and fine-tuning,
designed specifically for busy urology practices. Finally, the Flex Focus with
the BioJet system has a small footprint, enabling it to fit into tight spaces
in a clinic or practice. For more information, visit:
www.analogicultrasound.com/fusion.
Background
According to researchers, the innovative fusion of MRI and ultrasound may be a
better way to detect and assess prostate cancer, while helping men avoid
unnecessary biopsies. This technology blends real-time imaging from MRI and
ultrasound devices, allowing physicians to more accurately direct the biopsy
needle that draws cell samples from suspected tumors. The technology is part of
an overall approach to use MRI scans to determine which men need to undergo
prostate biopsy and then use MRI/ultrasound fusion to perform the most
efficient biopsy possible. MRI is also used during the biopsy, whereby an
electromagnetic field generator is placed over the patient's hip, creating
real-time MRI images that are combined with ultrasound images to guide the
needle biopsy. The images from the earlier MRI screening can then be overlaid
with the real-time images to provide visible targets for the physician to
biopsy1.
According to the American Cancer Society, prostate cancer is the most common
cancer in American men other than skin cancer. It is estimated in 2014 that
approximately 233,000 new cases of prostate cancer will be diagnosed and 29,480
men will die of the disease2.
About Analogic
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology
solutions to advance the practice of medicine and save lives. We are recognized
around the world for advanced imaging systems and technology that enable
computed tomography (CT), ultrasound, digital mammography, and magnetic
resonance imaging (MRI), as well as automated threat detection for aviation
security. Our CT, MRI, digital mammography, and ultrasound transducer products
are sold to original equipment manufacturers (OEMs), providing state-of-the-art
capability and enabling them to enter new markets and expand their existing
market presence. Our market-leading BK Medical and Ultrasonix branded
ultrasound systems, used in procedure-driven markets such as urology, surgery,
and point-of-care, are sold to clinical end users through our direct sales
force. For over 40 years we've enabled customers to thrive, improving the
health and enhancing the safety of people around the world. Analogic is
headquartered just north of Boston, Massachusetts. For more information, visit
www.analogic.com.
Analogic is a registered trademark of Analogic Corporation.
The globe logo is a trademark of Analogic Corporation.
1
http://health.usnews.com/health-news/news/articles/2013/08/16/high-tech-prostate
-scan-may-boost-cancer-detection
2
www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistic
s
CONTACT: For Further Information, Contact:
Media Contact:
Amy Cook
(925) 552-7893
amycook@amcpublicrelations.com
Investor Contact:
Mark Namaroff
Director of Investor Relations
(978) 326-4058
investorrelations@analogic.com
News Source: NASDAQ OMX
End of Corporate News
---------------------------------------------------------------------
09.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Analogic Corporation
United States
ISIN: US0326572072
End of News DGAP News-Service
---------------------------------------------------------------------
262514 09.04.2014
DGAP-News: Analogic Announces Agreement to Distribute Prostate Guidance Solution
| Quelle: EQS Group AG